What did we learn from Tamiflu?

BMJ Feature charts fortunes of this blockbuster pill and finds questions first raised over its effectiveness 10 years ago, and a negative Cochrane review from 2014, has not dented its success, with governments stockpiling neuraminidase inhibitors in vast quantities.

British Medical Journal